Cirrhotic cardiomyopathy: an endocannabinoid connection?
Pacher
Pál
P
LPS, NIAAA, NIH, Bethesda, MD 20892-9413, USA. pacher@mail.nih.gov
Bátkai
Sándor
S
Kunos
George
G
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000494:pharmacology*; D009202:Cardiomyopathies / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D063388:Endocannabinoids; D006801:Humans; D008106:Liver Cirrhosis, Experimental / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D009200:Myocardial Contraction / Q000187:drug effects; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043884:Receptor, Cannabinoid, CB1